Release: Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives, study shows
An antiviral drug commonly prescribed to treat hepatitis B infection does not significantly reduce mother-to-child transmission of hepatitis B virus, according to a clinical trial funded by NIH.